Wanbury eyes contract research firms in US
Wanbury, the largest global manufacturer of diabetes management drug metformin, plans to acquire contract research and manufacturing services (CRAMS) companies in the US and Europe.
More: continued here
Wanbury, the largest global manufacturer of diabetes management drug metformin, plans to acquire contract research and manufacturing services (CRAMS) companies in the US and Europe.
More: continued here
You must be logged in to post a comment.